The previous research showed that effective anti-PD-1 treatment could decrease Tim-3 expression on the Treg cells of head and neck squamous cell carcinoma (HNSCC) tumors (14). This evidence concerns the gene HAVCR2 and head and neck squamous cell carcinoma.